EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals
The European Union and the United States yesterday delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
The recognition yesterday by the U.S. Food and Drug Administration (FDA) of Slovakia, the last outstanding EU Member State, marks the full implementation of the EU-U.S. Mutual Recognition Agreement (MRA) for inspections of manufacturing sites for human medicines in their respective territories. This can make it faster and less costly for both sides to bring medicines to the market.
Commissioner Vytenis Andriukaitis, in charge of Health and Food Safety yesterday said:
"The completion of the Mutual Recognition Agreement is not only a step forward in the trade relations between the EU and the U.S., but it will also ensure high quality medicines for the benefit of patients. It means that, on both sides of the Atlantic, the authorities in charge of medicines can now rely on inspections results to replace their own inspections. Today, the U.S. Food and Drug Administration has completed the capability assessments of the 28 EU competent authorities, the result of five years of close transatlantic cooperation”.
This Mutual Recognition Agreement is underpinned by robust evidence that the EU and the U.S. have comparable procedures to carry out good manufacturing practice inspections for human medicines.
Together, Europe and the United States account for more than 80% of global sales of new medicines. As a result of the full implementation of this agreement, both the industry and public authorities on both sides will be able to free resources that could be used to inspect facilities in other large producing countries.
The pharmaceutical industry is a strategic sector in which EU-U.S. regulatory cooperation is much more advanced than in most other sectors. Since May 2014, teams from the European Commission, EU national competent authorities, the European Medicines Agency (EMA) and the U.S. Food and Drug Administration have been auditing and assessing the respective supervisory systems. The U.S. Food and Drug Administration has now assessed positively all national competent authorities of the EU.
From now on, the batch testing waiver will also start to apply. This means that the qualified persons in the EU pharmaceutical company will be relieved of their task for carrying out the quality controls when carried out already in the United States.
The Mutual Recognition Agreement implementation work will continue with view to expanding the operational scope to veterinary medicines, human vaccines and plasma derived medicinal products.
In 1998, the EU and the U.S. signed a broad Mutual Recognition Agreement, which included a Pharmaceutical Annex providing for anticipated and limited reliance on each other's Good Manufacturing Practices (GMP) inspections.
2017 marked the entry into operation of the agreement between the EU and the U.S. to recognise inspections of manufacturing sites for human medicines conducted in their respective territories. This agreement strengthens reliance upon each other's inspection expertise and resources. Initially it applied between the U.S. Food and Drug Administration and those EU Member States that the U.S. Food and Drug Administration had assessed. This has been gradually extended to all EU countries and now the regulatory authorities in all 28 EU Member States were recognised by the U.S. Food and Drug Administration. Meanwhile, the EU made the same determination about U.S. Food and Drug Administration in June 2017.
Latest News from
EU Blue Card: Commission welcomes political agreement on new rules for highly skilled migrant workers18/05/2021 12:33:00
The Commission welcomes the agreement reached today by the European Parliament and the Council on new rules for the entry and residence of highly skilled workers from outside the EU under the revised Blue Card Directive.
Nagorno Karabakh conflict: EU allocates additional €10 million to support those affected18/05/2021 09:25:00
As part of its efforts to strengthen resilience and peace building in the South Caucasus, the Commission is delivering on its pledge to contribute an additional €10 million in humanitarian aid, including some very early recovery to help civilians affected by the recent conflict in and around Nagorno Karabakh.
Recovery and Resilience Facility: Croatia and Lithuania submit official recovery and resilience plans17/05/2021 15:25:00
The Commission has received official recovery and resilience plans from Croatia and Lithuania.
Speech by President von der Leyen on the occasion of the Christchurch Call Second Anniversary Summit17/05/2021 13:25:00
Speech given recently (14 May 2021) by President von der Leyen on the occasion of the Christchurch Call Second Anniversary Summit.
International Day Against Homophobia, Transphobia and Biphobia, 17 May 2021: Declaration by the High Representative on behalf of the EU17/05/2021 12:38:00
Everyone is born free and equal in dignity and rights. On the International Day against Homophobia, Transphobia and Biphobia (IDAHOT), the European Union reaffirms its strong commitment to respect, protect and promote the full and equal enjoyment of human rights of lesbian, gay, bisexual, transgender and intersex (LGBTI) persons.
Spring 2021 Economic Forecast: Rolling up sleeves14/05/2021 13:25:00
The Spring 2021 Economic Forecast projects that the EU economy will expand by 4.2% in 2021 and by 4.4% in 2022.
Coronavirus variants: Commission calls for limiting essential travel from India14/05/2021 09:25:00
The Commission calls on EU Member States to take coordinated action to further restrict travel from India on a temporary basis, with a view to limiting the spread of the B.1.617.2 variant first detected in India.
Statement by Executive Vice-President Margrethe Vestager following today's Court judgments on the Amazon and Engie tax State aid cases in Luxembourg13/05/2021 15:25:00
Statement given yesterday by Executive Vice-President Margrethe Vestager following the Court judgments on the Amazon and Engie tax State aid cases in Luxembourg.
Europe's Digital Decade: Commission launches consultation and discussion on EU digital principles13/05/2021 13:25:00
As a follow-up to its Digital Decade Communication of 9 March, the Commission yesterday launched a public consultation on the formulation of a set of principles to promote and uphold EU values in the digital space.
European Green Deal: Commission aims for zero pollution in air, water and soil13/05/2021 12:43:00
The European Commission yesterday adopted the EU Action Plan: “Towards Zero Pollution for Air, Water and Soil” – a key deliverable of the European Green Deal and the main topic of this year's EU Green Week.